International Flavors & Fragrances (IFF) FY2024 10-K Annual Report
International Flavors & Fragrances (IFF) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 28, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
International Flavors & Fragrances FY2024 10-K Analysis
Business Overview
- • Core business: Creator and manufacturer of flavors, fragrances, health & biosciences, natural ingredients for consumer products across food, personal care, pharma
- • New focus: Emphasized goodwill impairment testing for Nourish and Health & Biosciences segments with combined $7.615B goodwill balance
- • Strategic shift: Recognized impairment charges fell sharply to $64M in 2024 from $2.623B in 2023, indicating improved asset valuation
- • Quantitative highlight: Net income $247M in 2024 vs net loss $2.567B in 2023; goodwill balance decreased from $10.635B to $9.080B
- • Noteworthy fact: Record $3.030B assets held for sale at year-end 2024 vs $506M in 2023, reflecting significant divestitures or restructurings
Management Discussion & Analysis
- • Operating cash flow $1.070B (9.3% of sales) in 2024 vs $1.439B (12.5% of sales) in 2023, decline due to working capital increase
- • Dividends paid $514M in 2024 vs $826M in 2023, dividend per share $1.60 vs $3.24; capital spending expected ~6% of sales in 2025
- • Net debt $8.534B with net debt to credit adjusted EBITDA ratio 3.84x, below covenant limits; no borrowings under $2B Revolving Credit Facility at year-end
- • Goodwill impairment charge $64M in 2024 on Pharma Solutions disposal group; expected additional $1.0B-$1.5B goodwill impairment Q1 2025 from Nourish segment restructuring
- • Management outlook highlights inflationary cost pressures, supply chain challenges, commitment to debt reduction, maintaining dividends capped at $3.24 per share annually through 2025 covenant relief period
Risk Factors
- • Ongoing U.S. and European antitrust investigations and related class action lawsuits risk fines and operational restrictions impacting results and liquidity
- • Geopolitical tensions including Russia-Ukraine war and Israel-Hamas conflict disrupting raw material supply and operations in affected regions
- • Reliance on limited suppliers for critical raw materials with no readily available alternatives, risking production delays and margin pressure
- • Strategic divestitures ongoing with Pharma Solutions and nitrocellulose business sales expected to close Q2 2025, execution risk impacting financial condition
- • Total debt $8.977B with leverage covenant relief through Dec 31, 2025 limiting share repurchases and dividends to $0.81/share per quarter
International Flavors & Fragrances FY2024 Key Financial MetricsXBRL
Revenue
$11.5B
▲ +0.0% YoY
Net Income
$243M
▲ +109.5% YoY
Gross Margin
35.9%
▲ +384bp YoY
Operating Margin
6.7%
▲ +2505bp YoY
Net Margin
2.1%
▲ +2448bp YoY
ROE
1.8%
▲ +1932bp YoY
Total Assets
$28.7B
▼ -7.5% YoY
EPS (Diluted)
$0.95
▲ +109.5% YoY
Operating Cash Flow
$1.1B
▼ -25.6% YoY
Source: XBRL data from International Flavors & Fragrances FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other International Flavors & Fragrances Annual Reports
Get deeper insights on International Flavors & Fragrances
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.